Abstract
| Original language | English |
|---|---|
| Article number | CD014871 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2021 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 20 Sept 2021 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cochrane Database of Systematic Reviews, Vol. 2021, No. 9, CD014871, 20.09.2021.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Ankle-foot orthoses for improving walking in people with calf muscle weakness due to neuromuscular disorders
AU - van Duijnhoven, Elza
AU - Waterval, Niels F.
AU - Koopman, Fieke Sophia
AU - Esquenazi, Alberto
AU - Tyson, Sarah
AU - Nollet, Frans
AU - Brehm, Merel-Anne
N1 - Funding Information: The Methods section of this protocol is based on a template developed by Cochrane Neuromuscular from an original created by the Cochrane Airways Group. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Neuromuscular Disease Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. Cochrane Neuromuscular is also supported by the Queen Square Centre for Neuromuscular Diseases. We acknowledge peer review comments and suggestions from: Sarah Nevitt, Post-Doctoral Research Associate, Department of Biostatistics, University of Liverpool. Roy Bowers, Principal Teaching Fellow, National Centre for Prosthetics and Orthotics, Department of Biomedical Engineering, University of Strathclyde. Aljwhara Alangary, Department of Anatomy, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Queen Square Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK. Sarah Nevitt, Post-Doctoral Research Associate, Department of Biostatistics, University of Liverpool. Roy Bowers, Principal Teaching Fellow, National Centre for Prosthetics and Orthotics, Department of Biomedical Engineering, University of Strathclyde. Aljwhara Alangary, Department of Anatomy, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Queen Square Centre for Neuromuscular Diseases, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK. Funding Information: FSK works as a rehabilitation physician delivering orthotic care for people with neurological conditions. She is involved in research for which her institution receives funding from orthotics companies (Fior and Gentz, Germany; OIM Orthopedie, The Netherlands). She was involved in a study funded by Princes Beatrix Speirfonds eligible for inclusion in the review. Funding Information: This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Neuromuscular Disease Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. Cochrane Neuromuscular is also supported by the Queen Square Centre for Neuromuscular Diseases. Funding Information: ST is employed by the University of Manchester and holds research projects funded by NIHR which are unrelated to the topic of this review. Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2021/9/20
Y1 - 2021/9/20
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of AFOs for improving walking in adults with calf muscle weakness due to slowly progressive NMD.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of AFOs for improving walking in adults with calf muscle weakness due to slowly progressive NMD.
UR - http://www.scopus.com/inward/record.url?scp=85115835944&partnerID=8YFLogxK
U2 - https://doi.org/10.1002/14651858.CD014871
DO - https://doi.org/10.1002/14651858.CD014871
M3 - Article
SN - 1465-1858
VL - 2021
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 9
M1 - CD014871
ER -